UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
7226
BCP Investment Corp
BCIC
$76.4M
| $79.4K | ﹤0.01% |
10,912
+4,796
| +78% | +$36.7K |
2014 Q4
46 quarters
|
|
7227
VanEck Oil Refiners ETF
CRAK
$642M
| $79.4K | ﹤0.01% |
1,723
+296
| +21% | +$14.3K |
2021 Q1
21 quarters
|
|
7228
InterPrivate Investment Partners V Units
IPVVU
| $79.4K | ﹤0.01% |
+8,000
| New | +$79.4K |
2026 Q2
0 quarters
|
|
7229
Madison Covered Call & Equity Strategy Fund
MCN
$113M
| $79.3K | ﹤0.01% |
14,363
+147
| +1% | +$855 |
2014 Q4
46 quarters
|
|
7230
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$113M
| $79.3K | ﹤0.01% |
8,578
+2,378
| +38% | +$21.9K |
2014 Q4
46 quarters
|
|
7231
Femasys
FEMY
$11.5M
| $78.5K | ﹤0.01% |
18,777
+15,681
| +506% | +$109K |
2025 Q2
4 quarters
|
|
7232
Innovator Equity Dual Directional 10 Buffer ETF - November
DDTN
$35.5M
| $78.5K | ﹤0.01% |
3,849
+3,424
| +806% | +$68.4K |
2025 Q4
2 quarters
|
|
7233
Clough Global Opportunities Fund
GLO
$235M
| $78.4K | ﹤0.01% |
12,810
+2,320
| +22% | +$13.7K |
2014 Q4
46 quarters
|
|
7234
First Trust Eurozone AlphaDEX
FEUZ
$114M
| $78.4K | ﹤0.01% |
1,181
+511
| +76% | +$34.3K |
2025 Q4
2 quarters
|
|
7235
NeuroSense Therapeutics
NRSN
$3.19M
| $78.2K | ﹤0.01% |
5,432
+2,977
| +121% | +$46.4K |
2025 Q1
5 quarters
|
|
7236
Acrivon Therapeutics
ACRV
$69M
| $78.1K | ﹤0.01% |
43,850
+9,216
| +27% | +$15.7K |
2024 Q1
9 quarters
|
|
7237
Atlas Critical Minerals Corp
ATCX
$10.6M
| $78.1K | ﹤0.01% |
22,080
+1,098
| +5% | +$5.26K |
2026 Q1
1 quarter
|
|
7238
Rareview Tax Advantaged Income ETF
RTAI
$16.5M
| $77.7K | ﹤0.01% |
3,572
+2,945
| +470% | +$62.6K |
2024 Q4
6 quarters
|
|
7239
Werewolf Therapeutics
HOWL
$49.1M
| $77.7K | ﹤0.01% |
215,838
+148,981
| +223% | +$90.8K |
2021 Q2
20 quarters
|
|
7240
CareCloud
CCLD
$97.9M
| $77.3K | ﹤0.01% |
36,458
+22,942
| +170% | +$59.3K |
2018 Q4
30 quarters
|
|
7241
Vulcan Infrastructure and Power
VIP
$17.8M
| $77.2K | ﹤0.01% |
43,131
-6,798
| -14% | -$9.23K |
2021 Q3
19 quarters
|
|
7242
STAK Inc
STAK
$62.6M
| $77.1K | ﹤0.01% |
20,236
+12,147
| +150% | +$28.6K |
2025 Q1
5 quarters
|
|
7243
PUT
Citizens Financial Group
CFG
$26.5B
| $77.1K | ﹤0.01% |
1,100
| – | – |
2025 Q2
4 quarters
|
|
7244
Roundhill T-REX 2X Long DRAM Daily Target ETF
RAM
$235M
| $77.1K | ﹤0.01% |
+2,964
| New | +$75.9K |
2026 Q2
0 quarters
|
|
7245
Future Vision II Acquisition Corp Units
FVNNU
$214M
| $76.7K | ﹤0.01% |
7,202
| – | – |
2024 Q3
7 quarters
|
|
7246
Zeo Energy
ZEO
$9.6M
| $76.6K | ﹤0.01% |
115,994
+114,363
| +7,012% | +$91.3K |
2023 Q4
10 quarters
|
|
7247
ACRES Commercial Realty
ACR
$189M
| $76.6K | ﹤0.01% |
4,303
-2,125
| -33% | -$41.5K |
2025 Q2
4 quarters
|
|
7248
AdvisorShares MSOS 2X Daily ETF
MSOX
$48.4M
| $76.5K | ﹤0.01% |
22,841
+15,118
| +196% | +$48K |
2025 Q4
2 quarters
|
|
7249
PS International Group
PSIG
$78.1M
| $76.4K | ﹤0.01% |
+60,136
| New | +$456K |
2026 Q2
0 quarters
|
|
7250
Coda Octopus Group
CODA
$94.1M
| $75.9K | ﹤0.01% |
7,772
-9,588
| -55% | -$111K |
2017 Q3
35 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,282 new, 4,216 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,282 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.